홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-(3-Chlorophenyl)piperazine → 3-{3-[4-(3-chlorophenyl)-piperazin-1-yl]-propyl}-3-ethyl-1,3-dihydro-2H-indol-2-one

HRID 506935
인쇄

반응식

HRID 506935 반응식
Cl[CH2:2][CH2:3][CH2:4][C:5]1([CH2:15][CH3:16])[C:13]2[C:8](=[CH:9][CH:10]=[CH:11][CH:12]=2)[NH:7][C:6]1=[O:14].[Cl:17][C:18]1[CH:19]=[C:20]([N:24]2[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]2)[CH:21]=[CH:22][CH:23]=1>>[Cl:17][C:18]1[CH:19]=[C:20]([N:24]2[CH2:29][CH2:28][N:27]([CH2:2][CH2:3][CH2:4][C:5]3([CH2:15][CH3:16])[C:13]4[C:8](=[CH:9][CH:10]=[CH:11][CH:12]=4)[NH:7][C:6]3=[O:14])[CH2:26][CH2:25]2)[CH:21]=[CH:22][CH:23]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 13551-(3-Chlorophenyl)piperazineHCID 684652713-(3-Chloropropyl)-3-ethyl-1,3-dihydro-2H-indol-2-one

생성물 1

HCID 248541093-{3-[4-(3-chlorophenyl)-piperazin-1-yl]-propyl}-3-ethyl-1,3-dihydro-2H-indol-2-one

실험 절차

The title compound is prepared according to process H by applying processing method 1 starting from 3-(3-chloropropyl)-3-ethyl-1,3-dihydro-2H-indol-2-one and 1-(3-chlorophenyl)-piperazine.

출처 및 근거

ORD 기록
ord-9360ef9b46744cf28039c6f5761a1590
출처 데이터셋
uspto-grants-2010_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07786129B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트